checkAd
    Startseite > Aktien > Turnstone Biologics > Nachrichten
    Turnstone Biologics
    Aktie
    ISIN: US90042W1009 WKN: A3EMMR SYM: TSBX Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    2,7000
     
    USD
    -3,57 %
    -0,1000 USD
    Letzter Kurs 15.06.24 Nasdaq
    Geldkurs
    14.06.24
    2,6800
     
    USD
    1.500 STK
    Briefkurs
    14.06.24
    2,7000
     
    USD
    900 STK

    Turnstone Biologics Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    13.05.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
    08.05.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    16.04.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
    21.03.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Participate in Upcoming Investor Conferences
    21.02.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
    20.02.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    27.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
    10.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    03.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
    30.10.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
    28.09.23 · globenewswire · Turnstone Biologics